Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

FDA approves Genzyme’s AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing multiple sclerosis
Radiation-induced brain injury: low-hanging fruit for neuroregeneration.
Vision Disturbances in Multiple Sclerosis.
Sox10 Expression in Goldfish Retina and Optic Nerve Head in Controls and after the Application of Two Different Lesion Paradigms.
Potassium channel KIR4.1 as an immune target in multiple sclerosis.
Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.
Effects of a 4-month Ananda Yoga Program on Physical and Mental Health Outcomes for Persons With Multiple Sclerosis.
Dimethyl Fumarate Inhibits the Nuclear Factor kappaB Pathway in Breast Cancer Cells by Covalent Modification of p65.
Data supporting the role of Fyn in initiating myelination in the peripheral nervous system.
Advanced Structural and Functional Brain MRI in Multiple Sclerosis.
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis.
Primary Progressive MS evolving from Radiologically Isolated Syndrome.
Treatment Options to Reduce Disease Activity After Natalizumab: Paradoxical Effects of Corticosteroids.
Geography in multiple sclerosis.
The budget impact of introducing delayed-release dimethyl fumarate for treatment of relapse-remitting multiple sclerosis in Canada.
[Assessment of the pain patients with the multiple sclerosis after applying the physiotherapy treatment].
Safety and tolerability of daclizumab HYP treatment in relapsing-remitting multiple sclerosis: results of the DECIDE study
Interferon beta 1a anaphylaxis, a case report. Standardization of non-irritating concentration for allergy skin.
Dimethyl fumarate regulates histone deacetylase expression in astrocytes.
Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial.
Quantifying brain volumes for Multiple Sclerosis patients follow-up in clinical practice - comparison of 1.5 and 3 Tesla magnetic resonance imaging.
Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS).
Polymorphism in Leptin and Leptin Receptor Genes May Modify Leptin Levels and Represent Risk Factors for Multiple Sclerosis.
Ampyra (Fampyra)
Dimethyl fumarate (BG-12, Tecfidera) approved for use by the NHS in Scotland

Pages